The global Therapeutic Radioisotopes market was valued at US$ 1771 million in 2023 and is anticipated to reach US$ 4734 million by 2030, witnessing a CAGR of 15.1% during the forecast period 2024-2030.

Therapeutic Radioisotopes Market

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Therapeutic Radioisotopes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Radioisotopes.

Report Scope

The Therapeutic Radioisotopes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Therapeutic Radioisotopes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Therapeutic Radioisotopes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Therapeutic Radioisotopes Market Report

Report Metric	Details
Report Name	Therapeutic Radioisotopes Market
Accounted market size in 2023	US$ 1771 million
Forecasted market size in 2030	US$ 4734 million
CAGR	15.1%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Radium-223 Lutetium-177 Iodine-131 Other
Segment by Application	Thyroid Bone Metastasis Lymphoma Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Bayer, Novartis, China Isotope & Radiation, Dongcheng, Q BioMed, Curium Pharmaceuticals, Jubilant Radiopharma, Lantheus, Aurobindo Pharma, International Isotopes, Mundipharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Therapeutic Radioisotopes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Therapeutic Radioisotopes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Therapeutic Radioisotopes Market growing?

Ans: The Therapeutic Radioisotopes Market witnessing a CAGR of 15.1% during the forecast period 2024-2030.

What is the Therapeutic Radioisotopes Market size in 2030?

Ans: The Therapeutic Radioisotopes Market size in 2030 will be US$ 4734 million.

Who are the main players in the Therapeutic Radioisotopes Market report?

Ans: The main players in the Therapeutic Radioisotopes Market are Bayer, Novartis, China Isotope & Radiation, Dongcheng, Q BioMed, Curium Pharmaceuticals, Jubilant Radiopharma, Lantheus, Aurobindo Pharma, International Isotopes, Mundipharma

What are the Application segmentation covered in the Therapeutic Radioisotopes Market report?

Ans: The Applications covered in the Therapeutic Radioisotopes Market report are Thyroid, Bone Metastasis, Lymphoma, Other

What are the Type segmentation covered in the Therapeutic Radioisotopes Market report?

Ans: The Types covered in the Therapeutic Radioisotopes Market report are Radium-223, Lutetium-177, Iodine-131, Other

1 Therapeutic Radioisotopes Market Overview

1.1 Product Overview and Scope of Therapeutic Radioisotopes

1.2 Therapeutic Radioisotopes Segment by Type

1.2.1 Global Therapeutic Radioisotopes Market Value Comparison by Type (2024-2030)

1.2.2 Radium-223

1.2.3 Lutetium-177

1.2.4 Iodine-131

1.2.5 Other

1.3 Therapeutic Radioisotopes Segment by Application

1.3.1 Global Therapeutic Radioisotopes Market Value by Application: (2024-2030)

1.3.2 Thyroid

1.3.3 Bone Metastasis

1.3.4 Lymphoma

1.3.5 Other

1.4 Global Therapeutic Radioisotopes Market Size Estimates and Forecasts

1.4.1 Global Therapeutic Radioisotopes Revenue 2019-2030

1.4.2 Global Therapeutic Radioisotopes Sales 2019-2030

1.4.3 Global Therapeutic Radioisotopes Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Therapeutic Radioisotopes Market Competition by Manufacturers

2.1 Global Therapeutic Radioisotopes Sales Market Share by Manufacturers (2019-2024)

2.2 Global Therapeutic Radioisotopes Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Therapeutic Radioisotopes Average Price by Manufacturers (2019-2024)

2.4 Global Therapeutic Radioisotopes Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Therapeutic Radioisotopes, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Therapeutic Radioisotopes, Product Type & Application

2.7 Therapeutic Radioisotopes Market Competitive Situation and Trends

2.7.1 Therapeutic Radioisotopes Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Therapeutic Radioisotopes Players Market Share by Revenue

2.7.3 Global Therapeutic Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Therapeutic Radioisotopes Retrospective Market Scenario by Region

3.1 Global Therapeutic Radioisotopes Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Therapeutic Radioisotopes Global Therapeutic Radioisotopes Sales by Region: 2019-2030

3.2.1 Global Therapeutic Radioisotopes Sales by Region: 2019-2024

3.2.2 Global Therapeutic Radioisotopes Sales by Region: 2025-2030

3.3 Global Therapeutic Radioisotopes Global Therapeutic Radioisotopes Revenue by Region: 2019-2030

3.3.1 Global Therapeutic Radioisotopes Revenue by Region: 2019-2024

3.3.2 Global Therapeutic Radioisotopes Revenue by Region: 2025-2030

3.4 North America Therapeutic Radioisotopes Market Facts & Figures by Country

3.4.1 North America Therapeutic Radioisotopes Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Therapeutic Radioisotopes Sales by Country (2019-2030)

3.4.3 North America Therapeutic Radioisotopes Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Therapeutic Radioisotopes Market Facts & Figures by Country

3.5.1 Europe Therapeutic Radioisotopes Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Therapeutic Radioisotopes Sales by Country (2019-2030)

3.5.3 Europe Therapeutic Radioisotopes Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Therapeutic Radioisotopes Market Facts & Figures by Country

3.6.1 Asia Pacific Therapeutic Radioisotopes Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Therapeutic Radioisotopes Sales by Country (2019-2030)

3.6.3 Asia Pacific Therapeutic Radioisotopes Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Therapeutic Radioisotopes Market Facts & Figures by Country

3.7.1 Latin America Therapeutic Radioisotopes Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Therapeutic Radioisotopes Sales by Country (2019-2030)

3.7.3 Latin America Therapeutic Radioisotopes Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Therapeutic Radioisotopes Market Facts & Figures by Country

3.8.1 Middle East and Africa Therapeutic Radioisotopes Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Therapeutic Radioisotopes Sales by Country (2019-2030)

3.8.3 Middle East and Africa Therapeutic Radioisotopes Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Therapeutic Radioisotopes Sales by Type (2019-2030)

4.1.1 Global Therapeutic Radioisotopes Sales by Type (2019-2024)

4.1.2 Global Therapeutic Radioisotopes Sales by Type (2025-2030)

4.1.3 Global Therapeutic Radioisotopes Sales Market Share by Type (2019-2030)

4.2 Global Therapeutic Radioisotopes Revenue by Type (2019-2030)

4.2.1 Global Therapeutic Radioisotopes Revenue by Type (2019-2024)

4.2.2 Global Therapeutic Radioisotopes Revenue by Type (2025-2030)

4.2.3 Global Therapeutic Radioisotopes Revenue Market Share by Type (2019-2030)

4.3 Global Therapeutic Radioisotopes Price by Type (2019-2030)

5 Segment by Application

5.1 Global Therapeutic Radioisotopes Sales by Application (2019-2030)

5.1.1 Global Therapeutic Radioisotopes Sales by Application (2019-2024)

5.1.2 Global Therapeutic Radioisotopes Sales by Application (2025-2030)

5.1.3 Global Therapeutic Radioisotopes Sales Market Share by Application (2019-2030)

5.2 Global Therapeutic Radioisotopes Revenue by Application (2019-2030)

5.2.1 Global Therapeutic Radioisotopes Revenue by Application (2019-2024)

5.2.2 Global Therapeutic Radioisotopes Revenue by Application (2025-2030)

5.2.3 Global Therapeutic Radioisotopes Revenue Market Share by Application (2019-2030)

5.3 Global Therapeutic Radioisotopes Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Bayer

6.1.1 Bayer Corporation Information

6.1.2 Bayer Description and Business Overview

6.1.3 Bayer Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Bayer Therapeutic Radioisotopes Product Portfolio

6.1.5 Bayer Recent Developments/Updates

6.2 Novartis

6.2.1 Novartis Corporation Information

6.2.2 Novartis Description and Business Overview

6.2.3 Novartis Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Novartis Therapeutic Radioisotopes Product Portfolio

6.2.5 Novartis Recent Developments/Updates

6.3 China Isotope & Radiation

6.3.1 China Isotope & Radiation Corporation Information

6.3.2 China Isotope & Radiation Description and Business Overview

6.3.3 China Isotope & Radiation Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.3.4 China Isotope & Radiation Therapeutic Radioisotopes Product Portfolio

6.3.5 China Isotope & Radiation Recent Developments/Updates

6.4 Dongcheng

6.4.1 Dongcheng Corporation Information

6.4.2 Dongcheng Description and Business Overview

6.4.3 Dongcheng Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Dongcheng Therapeutic Radioisotopes Product Portfolio

6.4.5 Dongcheng Recent Developments/Updates

6.5 Q BioMed

6.5.1 Q BioMed Corporation Information

6.5.2 Q BioMed Description and Business Overview

6.5.3 Q BioMed Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Q BioMed Therapeutic Radioisotopes Product Portfolio

6.5.5 Q BioMed Recent Developments/Updates

6.6 Curium Pharmaceuticals

6.6.1 Curium Pharmaceuticals Corporation Information

6.6.2 Curium Pharmaceuticals Description and Business Overview

6.6.3 Curium Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Curium Pharmaceuticals Therapeutic Radioisotopes Product Portfolio

6.6.5 Curium Pharmaceuticals Recent Developments/Updates

6.7 Jubilant Radiopharma

6.6.1 Jubilant Radiopharma Corporation Information

6.6.2 Jubilant Radiopharma Description and Business Overview

6.6.3 Jubilant Radiopharma Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Jubilant Radiopharma Therapeutic Radioisotopes Product Portfolio

6.7.5 Jubilant Radiopharma Recent Developments/Updates

6.8 Lantheus

6.8.1 Lantheus Corporation Information

6.8.2 Lantheus Description and Business Overview

6.8.3 Lantheus Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Lantheus Therapeutic Radioisotopes Product Portfolio

6.8.5 Lantheus Recent Developments/Updates

6.9 Aurobindo Pharma

6.9.1 Aurobindo Pharma Corporation Information

6.9.2 Aurobindo Pharma Description and Business Overview

6.9.3 Aurobindo Pharma Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Aurobindo Pharma Therapeutic Radioisotopes Product Portfolio

6.9.5 Aurobindo Pharma Recent Developments/Updates

6.10 International Isotopes

6.10.1 International Isotopes Corporation Information

6.10.2 International Isotopes Description and Business Overview

6.10.3 International Isotopes Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.10.4 International Isotopes Therapeutic Radioisotopes Product Portfolio

6.10.5 International Isotopes Recent Developments/Updates

6.11 Mundipharma

6.11.1 Mundipharma Corporation Information

6.11.2 Mundipharma Therapeutic Radioisotopes Description and Business Overview

6.11.3 Mundipharma Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Mundipharma Therapeutic Radioisotopes Product Portfolio

6.11.5 Mundipharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Therapeutic Radioisotopes Industry Chain Analysis

7.2 Therapeutic Radioisotopes Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Therapeutic Radioisotopes Production Mode & Process

7.4 Therapeutic Radioisotopes Sales and Marketing

7.4.1 Therapeutic Radioisotopes Sales Channels

7.4.2 Therapeutic Radioisotopes Distributors

7.5 Therapeutic Radioisotopes Customers

8 Therapeutic Radioisotopes Market Dynamics

8.1 Therapeutic Radioisotopes Industry Trends

8.2 Therapeutic Radioisotopes Market Drivers

8.3 Therapeutic Radioisotopes Market Challenges

8.4 Therapeutic Radioisotopes Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Bayer

Novartis

China Isotope & Radiation

Dongcheng

Q BioMed

Curium Pharmaceuticals

Lantheus

International Isotopes

Jubilant Radiopharma

Aurobindo Pharma

Mundipharma

List of Tables

Table 1. Global Therapeutic Radioisotopes Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Therapeutic Radioisotopes Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Therapeutic Radioisotopes Market Competitive Situation by Manufacturers in 2023

Table 4. Global Therapeutic Radioisotopes Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Therapeutic Radioisotopes Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Therapeutic Radioisotopes Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Therapeutic Radioisotopes Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Therapeutic Radioisotopes Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Therapeutic Radioisotopes, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Therapeutic Radioisotopes, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Therapeutic Radioisotopes, Product Type & Application

Table 12. Global Key Manufacturers of Therapeutic Radioisotopes, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Therapeutic Radioisotopes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Radioisotopes as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Therapeutic Radioisotopes Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Therapeutic Radioisotopes Sales by Region (2019-2024) & (K Units)

Table 18. Global Therapeutic Radioisotopes Sales Market Share by Region (2019-2024)

Table 19. Global Therapeutic Radioisotopes Sales by Region (2025-2030) & (K Units)

Table 20. Global Therapeutic Radioisotopes Sales Market Share by Region (2025-2030)

Table 21. Global Therapeutic Radioisotopes Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Therapeutic Radioisotopes Revenue Market Share by Region (2019-2024)

Table 23. Global Therapeutic Radioisotopes Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Therapeutic Radioisotopes Revenue Market Share by Region (2025-2030)

Table 25. North America Therapeutic Radioisotopes Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Therapeutic Radioisotopes Sales by Country (2019-2024) & (K Units)

Table 27. North America Therapeutic Radioisotopes Sales by Country (2025-2030) & (K Units)

Table 28. North America Therapeutic Radioisotopes Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Therapeutic Radioisotopes Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Therapeutic Radioisotopes Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Therapeutic Radioisotopes Sales by Country (2019-2024) & (K Units)

Table 32. Europe Therapeutic Radioisotopes Sales by Country (2025-2030) & (K Units)

Table 33. Europe Therapeutic Radioisotopes Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Therapeutic Radioisotopes Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Therapeutic Radioisotopes Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Therapeutic Radioisotopes Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Therapeutic Radioisotopes Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Therapeutic Radioisotopes Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Therapeutic Radioisotopes Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Therapeutic Radioisotopes Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Therapeutic Radioisotopes Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Therapeutic Radioisotopes Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Therapeutic Radioisotopes Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Therapeutic Radioisotopes Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Therapeutic Radioisotopes Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Therapeutic Radioisotopes Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Therapeutic Radioisotopes Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Therapeutic Radioisotopes Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Therapeutic Radioisotopes Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Therapeutic Radioisotopes Sales (K Units) by Type (2019-2024)

Table 51. Global Therapeutic Radioisotopes Sales (K Units) by Type (2025-2030)

Table 52. Global Therapeutic Radioisotopes Sales Market Share by Type (2019-2024)

Table 53. Global Therapeutic Radioisotopes Sales Market Share by Type (2025-2030)

Table 54. Global Therapeutic Radioisotopes Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Therapeutic Radioisotopes Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Therapeutic Radioisotopes Revenue Market Share by Type (2019-2024)

Table 57. Global Therapeutic Radioisotopes Revenue Market Share by Type (2025-2030)

Table 58. Global Therapeutic Radioisotopes Price (USD/Unit) by Type (2019-2024)

Table 59. Global Therapeutic Radioisotopes Price (USD/Unit) by Type (2025-2030)

Table 60. Global Therapeutic Radioisotopes Sales (K Units) by Application (2019-2024)

Table 61. Global Therapeutic Radioisotopes Sales (K Units) by Application (2025-2030)

Table 62. Global Therapeutic Radioisotopes Sales Market Share by Application (2019-2024)

Table 63. Global Therapeutic Radioisotopes Sales Market Share by Application (2025-2030)

Table 64. Global Therapeutic Radioisotopes Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Therapeutic Radioisotopes Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Therapeutic Radioisotopes Revenue Market Share by Application (2019-2024)

Table 67. Global Therapeutic Radioisotopes Revenue Market Share by Application (2025-2030)

Table 68. Global Therapeutic Radioisotopes Price (USD/Unit) by Application (2019-2024)

Table 69. Global Therapeutic Radioisotopes Price (USD/Unit) by Application (2025-2030)

Table 70. Bayer Corporation Information

Table 71. Bayer Description and Business Overview

Table 72. Bayer Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Bayer Therapeutic Radioisotopes Product

Table 74. Bayer Recent Developments/Updates

Table 75. Novartis Corporation Information

Table 76. Novartis Description and Business Overview

Table 77. Novartis Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. Novartis Therapeutic Radioisotopes Product

Table 79. Novartis Recent Developments/Updates

Table 80. China Isotope & Radiation Corporation Information

Table 81. China Isotope & Radiation Description and Business Overview

Table 82. China Isotope & Radiation Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. China Isotope & Radiation Therapeutic Radioisotopes Product

Table 84. China Isotope & Radiation Recent Developments/Updates

Table 85. Dongcheng Corporation Information

Table 86. Dongcheng Description and Business Overview

Table 87. Dongcheng Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. Dongcheng Therapeutic Radioisotopes Product

Table 89. Dongcheng Recent Developments/Updates

Table 90. Q BioMed Corporation Information

Table 91. Q BioMed Description and Business Overview

Table 92. Q BioMed Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. Q BioMed Therapeutic Radioisotopes Product

Table 94. Q BioMed Recent Developments/Updates

Table 95. Curium Pharmaceuticals Corporation Information

Table 96. Curium Pharmaceuticals Description and Business Overview

Table 97. Curium Pharmaceuticals Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Curium Pharmaceuticals Therapeutic Radioisotopes Product

Table 99. Curium Pharmaceuticals Recent Developments/Updates

Table 100. Jubilant Radiopharma Corporation Information

Table 101. Jubilant Radiopharma Description and Business Overview

Table 102. Jubilant Radiopharma Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. Jubilant Radiopharma Therapeutic Radioisotopes Product

Table 104. Jubilant Radiopharma Recent Developments/Updates

Table 105. Lantheus Corporation Information

Table 106. Lantheus Description and Business Overview

Table 107. Lantheus Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. Lantheus Therapeutic Radioisotopes Product

Table 109. Lantheus Recent Developments/Updates

Table 110. Aurobindo Pharma Corporation Information

Table 111. Aurobindo Pharma Description and Business Overview

Table 112. Aurobindo Pharma Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Aurobindo Pharma Therapeutic Radioisotopes Product

Table 114. Aurobindo Pharma Recent Developments/Updates

Table 115. International Isotopes Corporation Information

Table 116. International Isotopes Description and Business Overview

Table 117. International Isotopes Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. International Isotopes Therapeutic Radioisotopes Product

Table 119. International Isotopes Recent Developments/Updates

Table 120. Mundipharma Corporation Information

Table 121. Mundipharma Description and Business Overview

Table 122. Mundipharma Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 123. Mundipharma Therapeutic Radioisotopes Product

Table 124. Mundipharma Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Therapeutic Radioisotopes Distributors List

Table 128. Therapeutic Radioisotopes Customers List

Table 129. Therapeutic Radioisotopes Market Trends

Table 130. Therapeutic Radioisotopes Market Drivers

Table 131. Therapeutic Radioisotopes Market Challenges

Table 132. Therapeutic Radioisotopes Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Therapeutic Radioisotopes

Figure 2. Global Therapeutic Radioisotopes Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Therapeutic Radioisotopes Market Share by Type in 2023 & 2030

Figure 4. Radium-223 Product Picture

Figure 5. Lutetium-177 Product Picture

Figure 6. Iodine-131 Product Picture

Figure 7. Other Product Picture

Figure 8. Global Therapeutic Radioisotopes Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Therapeutic Radioisotopes Market Share by Application in 2023 & 2030

Figure 10. Thyroid

Figure 11. Bone Metastasis

Figure 12. Lymphoma

Figure 13. Other

Figure 14. Global Therapeutic Radioisotopes Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Therapeutic Radioisotopes Market Size (2019-2030) & (US$ Million)

Figure 16. Global Therapeutic Radioisotopes Sales (2019-2030) & (K Units)

Figure 17. Global Therapeutic Radioisotopes Average Price (USD/Unit) & (2019-2030)

Figure 18. Therapeutic Radioisotopes Report Years Considered

Figure 19. Therapeutic Radioisotopes Sales Share by Manufacturers in 2023

Figure 20. Global Therapeutic Radioisotopes Revenue Share by Manufacturers in 2023

Figure 21. The Global 5 and 10 Largest Therapeutic Radioisotopes Players: Market Share by Revenue in 2023

Figure 22. Therapeutic Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 23. Global Therapeutic Radioisotopes Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 24. North America Therapeutic Radioisotopes Sales Market Share by Country (2019-2030)

Figure 25. North America Therapeutic Radioisotopes Revenue Market Share by Country (2019-2030)

Figure 26. U.S. Therapeutic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Canada Therapeutic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Europe Therapeutic Radioisotopes Sales Market Share by Country (2019-2030)

Figure 29. Europe Therapeutic Radioisotopes Revenue Market Share by Country (2019-2030)

Figure 30. Germany Therapeutic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. France Therapeutic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. U.K. Therapeutic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Italy Therapeutic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Russia Therapeutic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Therapeutic Radioisotopes Sales Market Share by Region (2019-2030)

Figure 36. Asia Pacific Therapeutic Radioisotopes Revenue Market Share by Region (2019-2030)

Figure 37. China Therapeutic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Japan Therapeutic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. South Korea Therapeutic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. India Therapeutic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Australia Therapeutic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Taiwan Therapeutic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Indonesia Therapeutic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Thailand Therapeutic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Malaysia Therapeutic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Philippines Therapeutic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Latin America Therapeutic Radioisotopes Sales Market Share by Country (2019-2030)

Figure 48. Latin America Therapeutic Radioisotopes Revenue Market Share by Country (2019-2030)

Figure 49. Mexico Therapeutic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Brazil Therapeutic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Argentina Therapeutic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Middle East & Africa Therapeutic Radioisotopes Sales Market Share by Country (2019-2030)

Figure 53. Middle East & Africa Therapeutic Radioisotopes Revenue Market Share by Country (2019-2030)

Figure 54. Turkey Therapeutic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Therapeutic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. U.A.E Therapeutic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Global Sales Market Share of Therapeutic Radioisotopes by Type (2019-2030)

Figure 58. Global Revenue Market Share of Therapeutic Radioisotopes by Type (2019-2030)

Figure 59. Global Therapeutic Radioisotopes Price (USD/Unit) by Type (2019-2030)

Figure 60. Global Sales Market Share of Therapeutic Radioisotopes by Application (2019-2030)

Figure 61. Global Revenue Market Share of Therapeutic Radioisotopes by Application (2019-2030)

Figure 62. Global Therapeutic Radioisotopes Price (USD/Unit) by Application (2019-2030)

Figure 63. Therapeutic Radioisotopes Value Chain

Figure 64. Therapeutic Radioisotopes Production Process

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Distributors Profiles

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Endoparasiticide Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36H8345

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Herpes Zoster Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34R905

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global SGLT2 Inhibitor Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2R9930

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Seasonal Affective Disorder Therapeutics Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34L14446

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions